CEO in focus - Pureprofile's Martin Filz

March 24th, 2022 by Paul Langley
Read More

Servatus launches new trial into the effects of live biotherapeutics on insomnia

Servatus launches new trial into the effects of live biotherapeutics on insomnia, we talk to CEO Dr Wayne Finlayson to discuss this exciting initiative.

March 24th, 2022 by Michael Lovesey
Read More

Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer

Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)

March 23rd, 2022 by Cherie Hartley
Read More

Recent client coverage highlights

March 23rd, 2022 by Paul Langley
Read More

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

March 17th, 2022 by Jane Lowe
Read More